Perjeta

The latest in health news: a new cancer drug prolongs life, an FDA-approved device could be key in distinguishing between cognitive impairment and Alzheimer's disease, and why heart attacks may look very different in women
Last year, the advisory committee to the FDA voted to advise approval of a cancer drug, Perjeta, that could be used to treat breast cancer patients before surgery. Now, a new clinical trial sponsored by Swiss drug maker
Each year, about 220,000 individuals are diagnosed with early-stage breast cancer, according to Genentech. For those 15,000 patients eligible for preoperative treatment